Tetraphase Pharmaceuticals Inc. Company Profile
Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs such as the treatment of serious drug-resistant and gram-negative infections. The company has developed an emerging pipeline of potent novel antibiotics that provide a portfolio of intravenous and oral drug candidates with the potential to treat a wide range of infections, including broad-spectrum and selective-spectrum infections. To learn more about Tetraphase, please visit www.tphase.com.
News Articles
Antibiotics developer [TetraPhase Pharmaceuticals Inc.] has filed for its initial public offering.
Tetraphase, Aratana Make IPO Announcements
BRIEF: Tetraphase, Aratana Make IPO Announcements [Boston Herald] From Boston Herald (MA) (March 21, 2013) March 20--Tetraphase Pharmaceuticals Inc. today announced the pricing of its initial public o...
Tetraphase Pharmaceuticals Inc. (Watertown, Mass.) proposed to raise up to $86.3 million in an IPO underwritten by Barclays; BMO Capital Markets; Stifel; JMP Securities; and Needham. Tetraphase plans...
Tetraphase Pharmaceuticals to Present at the Annual UBS Global Healthcare Conference
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against dange...
Tetraphase floats IPO at $7 after two price cuts
After a series of price reductions, antibiotic developer Tetraphase Pharmaceuticals launched its initial public offering on 20 March with 10.7 million shares priced at $7 each for gross proceeds of $...
Tetraphase in IPO financing for $82 million
Tetraphase, which filed its intention to go public with the SEC last month, could raise as much as $82 million in IPO financing through the sale of 6.8 million shares at $10 to $12 a share Tetraphase,...
Tetraphase to Present at The JMP Securities Healthcare Conference
Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-re...
Tetraphase eyes partnership or float to take eravacycline into Phase III
Ahead of fundraising or partnership negotiations to finance Phase III development, Tetraphase Pharmaceuticals unveiled positive Phase II clinical trial data for its lead drug candidate, the intraveno...
Drugs and Medications
None
PubMed Articles
8-azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
A novel series of fully synthetic 8-azatetracyclines was prepared and evaluated for antibacterial activity. Compounds were identified that overcome both efflux (tet(K)) and ribosomal protection (tet(M...
Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.
Employing a highly efficient total synthesis approach, we synthesized and evaluated for antibacterial activity diverse and novel pentacycline analogs with systematic variations at C7, C8, C9, and C10....
Clinical Trials
None
Companies
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-gen...
Tetraphase Pharmaceuticals is a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the gl...
Tetraphase Pharmaceuticals Inc.
Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation...
More Information about "Tetraphase Pharmaceuticals Inc." on BioPortfolio
We have published hundreds of Tetraphase Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Tetraphase Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Tetraphase Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tetraphase Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Tetraphase Pharmaceuticals Inc. Drugs and Medications on this site too.
